Launching a new product in a packed pharmaceutical market requires an incisive marketing strategy. Learn more here: ...
Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Hosted on MSN
OKYO Pharma rings NASDAQ opening bell as Urcosimod advances after positive phase 2 NCP data
OKYO Pharma Limited Sponsored ADR ( (OKYO)) just unveiled an announcement. On December 19, 2025, OKYO Pharma marked its progress in developing treatments for neuropathic corneal pain by having ...
ORLANDO, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) ("Nutriband" or the "Company"), a developer of transdermal pharmaceutical products including ...
How is AI and data leadership at large organizations being transformed by the accelerating pace of AI adoption? Do these leaders’ mandates need to change? And should overseeing AI and data be viewed ...
The U.S. Food & Drug Administration (FDA) on Tuesday extended review for Ascendis Pharma A/S‘ (NASDAQ: ASND) New Drug Application (NDA) for TransCon CNP (navepegritide) for children with ...
Data from Italy's national railway operator, the FS Italiane Group, has been exposed after a threat actor breached the organization's IT services provider, Almaviva. The hacker claims to have stolen 2 ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback